Why Data Security Is So Important in Clinical Trial Translation Services

Clinical trials generate an enormous amount of data. From patient records and informed consent forms to regulatory submissions and lab reports, every document contains highly sensitive information. According to estimates from the Tufts Center for the Study of Drug Development, a single Phase III clinical trial can produce up to 3.6 million data points, a figure that has nearly tripled over the past decade as studies become more complex and digitized.

With this scale of information, the stakes for protecting it are extremely high. A data breach doesn’t just threaten compliance; it undermines patient trust, delays approvals, and can compromise the integrity of the trial itself.

The Risks of Exposed Clinical Data

Clinical trial documentation often contains:

• Personally Identifiable Information (PII) such as names, addresses, dates of birth, or contact details. This data is highly sensitive because it can be directly tied to an individual.
• Protected Health Information (PHI) includes medical histories, genetic profiles, treatment responses, or even biometric markers. These details are critical to research but also highly vulnerable if mishandled.
• Confidential business data, including drug formulations, trial methodologies, statistical analyses, and proprietary research findings. For sponsors, this is intellectual property that has been developed over years of investment.

When such data is exposed, the consequences extend far beyond financial costs. Risks include:

• Regulatory violations under laws such as HIPAA in the U.S. and GDPR in Europe can lead to investigations, multimillion-dollar fines, and long-term restrictions on research activities.
• Compromised intellectual property could allow competitors to gain unfair access to years of research and development, undermining innovation and competitive advantage.
• Loss of patient trust. Clinical trials depend on volunteers who are often already vulnerable due to illness. If their data is misused or disclosed, it can erode trust not only in the sponsor but in the entire research ecosystem, making future recruitment far more difficult.

This isn’t just a theoretical risk. The 2023 IBM Cost of a Data Breach Report revealed that healthcare data breaches carry an average cost of US$10.93 million per incident, the highest of any industry worldwide. That figure doesn’t account for long-term reputational damage, regulatory scrutiny, or trial delays caused by compliance investigations.

In short, a single breach can jeopardize years of research, undermine patient safety, and derail the path to market for life-saving therapies.

Why Translation Services Must Be Especially Vigilant

Translation providers working with clinical trial materials have a direct responsibility for safeguarding sensitive data. Each stage, whether transferring, storing, or processing files, introduces potential vulnerabilities. A single weak link in the chain can compromise an entire project. Unlike general translation work, clinical trial translation often involves:

• Multiple document types containing PHI/PII, such as informed consent forms, patient diaries, case report forms (CRFs), and regulatory submissions. These documents are not only medically sensitive but also personally identifiable.
• Regulatory compliance demands from Institutional Review Boards (IRBs) and global regulatory agencies require translations to meet strict timelines, formatting standards, and data protection measures.
• Tight timelines and high stakes, where even minor delays or errors can ripple into trial postponements, increased costs, or risks to patient safety.

Due to these challenges, language service providers (LSPs) must prioritize data security as a fundamental aspect of their operations, rather than an afterthought. This requires adopting robust, layered safeguards that protect both patient information and proprietary research data. Best practices typically include:

• Secure portals and encrypted communications for all document exchanges
• Strict use of non-disclosure agreements (NDAs) for translators/interpreters and staff
• Quality certifications, such as ISO standards, and regular audits
• Comprehensive internal quality assurance and review processes
• Assuring compliance with major data protection regulations (HIPAA, GDPR, other local laws)

As clinical trials continue to evolve, with the emergence of decentralized clinical trials, digital and remote data collection, eConsent platforms, and connected health devices, the sheer volume and complexity of data management will only continue to increase. The very systems that enable faster, richer insights also heighten the risk of exposure.

That is why it is critical to work with translation providers who not only understand the science but also bring the infrastructure, certifications, and most importantly, a security-first culture needed to protect sensitive information at every stage. A security-first culture ensures that data protection is not just a requirement but a core value that guides every decision and action.

What Sets DTS Apart in Protecting Sensitive Clinical Information?

DTS Language Services is an ISO-certified language service provider specializing in clinical trial translations, with more than 50 years of experience supporting life sciences organizations worldwide. What sets DTS apart is not only its deep subject-matter expertise and rigorous quality assurance, but also its unwavering commitment to data protection and security.

Every file entrusted to DTS is handled with the utmost care. Documents are transferred through HIPAA-secure channels, processed within a multi-tiered quality assurance framework, and returned on schedule with a clear audit trail to ensure full accountability. Confidentiality isn’t just promised. It’s embedded into every stage of the workflow.

DTS secures sensitive clinical information by using:

• Secure client portals for all file transfers.
• End-to-end encrypted communications to prevent unauthorized access.
• Strict NDAs and confidentiality agreements for every linguist, interpreter, and staff member.
• Comprehensive compliance measures, including ISO 17100 certification and adherence to HIPAA, GDPR, and other regional regulations.

This disciplined approach means clients can be confident that their translations are not only accurate and compliant but also protected by industry-leading security practices. At DTS, protecting your patients, your research, and your intellectual property is as important as delivering the translation itself.

At every stage of clinical trial translation, data security must be treated as a non-negotiable requirement. Accuracy without security is not enough; protecting sensitive information is equally important. For translation providers and trial sponsors alike, investing in secure protocols, trusted partners, and compliant systems is crucial to maintaining trust, protecting participants, and ensuring that clinical research achieves its goals.